Cardura XL (Doxazosin Mesylate) - Summary

CARDURA XL SUMMARY

CARDURA® XL
(doxazosin mesylate extended release tablets)

CARDURA XL (doxazosin mesylate extended release tablets) contains doxazosin mesylate which is a quinazoline compound with the chemical name 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl) piperazine methanesulfonate.

CARDURA XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

CARDURA XL is not indicated for the treatment of hypertension.

CARDURA XL NEWS HIGHLIGHTS

Media Articles Related to Cardura XL (Doxazosin)

Nymox's NX-1207 For The Treatment Of Benign Prostatic Hyperplasia In Phase 3 Program
Source: Prostate / Prostate Cancer News From Medical News Today [2008.09.24]

Benign Prostatic Hyperplasia
Source: MedicineNet Prostatitis Specialty [2008.06.23]

Medical and Surgical Treatment of Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: State of the Art
Source: Medscape Pharmacotherapy Headlines [2004.06.11]

more>>

Published Studies Related to Cardura XL (Doxazosin)

Effect of Vardenafil on Blood Pressure Profile of Patients With Erectile Dysfunction Concomitantly Treated With Doxazosin Gastrointestinal Therapeutic System for Benign Prostatic Hyperplasia. [2008.07.16]

Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. [2008]

Doxazosin for the management of distal-ureteral stones. [2007.05]

LC-MS determination and relative bioavailability of doxazosin mesylate tablets in healthy Chinese male volunteers. [2007.02.19]

Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study. [2007]

more>>

Clinical Trials Related to Cardura XL (Doxazosin)

Effects Of Doxazosin Gastrointestinal Therapeutic System On Ambulatory Blood Pressure And Cardiovascular Risk Factors In Uncontrolled Hypertensive Patients [Completed]

Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up [Terminated]

Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia [Recruiting]

Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy [Completed]

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension [Recruiting]

more>>